WILMINGTON, Del. and SUFFOLK, England -- DuPont today announced its acquisition of Antec International, a leading biosecurity company providing human and animal health emergency disease control. Antec products are used throughout the world to protect food supplies from viruses such as Foot and Mouth Disease (FMD) and the public from illness-causing germs such as the Norwalk-like virus that impacted the cruise ship industry last winter.
"This acquisition is a strategic fit for DuPont, building on our expertise in cleaning and disinfecting solutions that protect people, operations and the global food chain from the potential spread of virus and disease," said DuPont Chemical Solutions Enterprise vice president and general manager Nick C. Fanandakis. "We will continue to develop and strengthen the suite of biosecurity solutions produced by Antec while providing DuPont scientific innovations that further develop this important class of cleaning and disinfecting agents as part of our growing Clean & Disinfect business."
DuPont has been a supplier of the active ingredient in many Antec products for over 15 years. In 2001, DuPont and Antec joined forces to provide additional supplies of one of Antec's premier products -- Virkon S -- to over 100 countries during the height of the FMD outbreak. Antec products are used not only to attack disease outbreaks but also as a preventive agent, preventing infection before it starts.
"Our strong relationship with DuPont spans the past 15 years and is built upon our shared common goal -- to protect the global environment from the threat of disease," said Antec International chief executive Ralph Auchincloss. "Our broad range of effective products is tailored to specific disease challenges and conditions. They also are effective against new and emerging pathogens, yet are friendly to man, animals and the environment. With DuPont's strength in science and innovation and its global access to market, we view this as the next logical step for the growth of this business."
Source: DuPont
Building Infection Prevention Capacity in the Middle East: A 7-Year Certification Success Story
June 17th 2025Despite rapid development, the Middle East faces a critical shortage of certified infection preventionists. A 7-year regional initiative has significantly boosted infection control capacity, increasing the number of certified professionals and elevating patient safety standards across health care settings.
Streamlined IFU Access Boosts Infection Control and Staff Efficiency
June 17th 2025A hospital-wide quality improvement project has transformed how staff access critical manufacturer instructions for use (IFUs), improving infection prevention compliance and saving time through a standardized, user-friendly digital system supported by unit-based training and interdepartmental collaboration.
Swift Isolation Protocol Shields Chicago Children’s Hospital During 2024 Measles Surge
June 17th 2025When Chicago logged its first measles cases linked to crowded migrant shelters last spring, one pediatric hospital moved in hours—not days—to prevent the virus from crossing its threshold. Their playbook offers a ready template for the next communicable-disease crisis.
Back to Basics: Hospital Restores Catheter-Associated UTI Rates to Prepandemic Baseline
June 16th 2025A 758-bed quaternary medical center slashed catheter-associated urinary tract infections (CAUTIs) by 45% over 2 years, proving that disciplined adherence to fundamental prevention steps, not expensive add-ons, can reverse the pandemic-era spike in device-related harm.
Global Patients, Local Risks: Why Medical Tourism Demands Infection Preventionists’ Attention
June 16th 2025At APIC25, infection prevention leader Heather Stoltzfus, MPH, RN, CIC, will spotlight the growing risks and overlooked responsibilities associated with medical tourism. Her session urges infection preventionists to engage with a global health trend that directly impacts US care settings.